Why the study?
Does a telemonitoring system combined with lercanidipine improve blood pressure control in hypertensive patients with chronic kidney disease?
Observational (n=27)
Yes
Does a telemonitoring system combined with lercanidipine improve blood pressure control in hypertensive patients with chronic kidney disease?
The combined use of home telemetric blood pressure monitoring and lercanidipine significantly improved blood pressure control in patients with chronic kidney disease.
The quality of Blood Pressure (BP) control remains poor among patients with Chronic Kidney Diseases (CKD). It is therefore crucial to develop therapeutic strategies enabling improvement in BP control in order to retard the progression of the underlying renal diseases. The cornerstones of therapy include the use of effective and well tolerated drugs and a good drug adherence. In this pilot study conducted in ambulant routine care we evaluated the potential clinical benefits of implementing a Telemonitoring System (TMS) in parallel to an anticipated change of treatment in hypertensive CKD patients with uncontrolled hypertension and/or adverse reactions due to the current antihypertensive treatment.
No takes yet. Share an insight, caveat, or question.
M. Burnier (2012) conducted an observational in Hypertension with Chronic Kidney Disease (n=27). Telemonitoring System (TMS) and lercanidipine vs. Baseline (pre-intervention) was evaluated on Change in office systolic blood pressure (MD -10 mmHg, p=0.028).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: